Definitive Contract 36C25018C0008
Award Date
10/1/17
Potential Completion Date
9/30/22
Potential Value
$284K
Federal Agency
Veterans Integrated Service Network 10
Awardee
Genomic Health, Inc.
Ultimate Awardee
Exact Sciences Corporation
NAICS Category
622110 - General Medical and Surgical Hospitals
PSC Category
Q515 - Medical- Pathology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cleveland, OH 44106, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price delivery order contract to Genomic Health, Inc., a subsidiary of Exact Sciences Corp, to provide reference lab testing services. The contract, valued at $228,525.24, was issued under the Medical Laboratory Testing and Analysis Services schedule and did not have a set-aside designation. Genomic Health has previously held multiple federal contracts with the Department of Defense and VA to deliver its...
This is a definitive contract award to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for Oncotype testing services for cancer. The $325,998.94 firm fixed price contract was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 22 and does not have a set-aside designation. Genomic Health provides specialized genomic-based cancer diagnostic testing services, primarily focused on its Oncotype DX portfolio of tests that analyze gene expression...
This federal contract award to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, is for the provision of the company's Oncotype DX portfolio of cancer diagnostic assays. The contract, valued at $200,327.28, was awarded by the Veterans Integrated Service Network 6 (VISN 6) of the U.S. Department of Veterans Affairs (VA). It is a firm-fixed-price purchase order with a period of performance through September 30, 2025. The contract does not utilize a set-aside designation, as Genomic...
This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs Veterans Health Administration (VHA) to Genomic Health, Inc., a subsidiary of Exact Sciences Corp. The contract is for proprietary genetic testing services, specifically Genomic Health's Oncotype DX portfolio of cancer diagnostic assays, to support cancer screening, treatment selection, and disease monitoring for VHA patients. The contract has a potential value of $444,907.92 and a...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded a $226,115.40 firm fixed price delivery order to Genomic Health, Inc., a subsidiary of Exact Sciences Corp, for Genomic Oncotype breast, colon, and prostate cancer testing services. This order was placed under Genomic Health's existing Multiple Award Schedule contract for Medical Laboratory Testing and Analysis Services. Genomic Health has a history of providing cancer testing...
This is a $6,385.84 firm fixed price contract awarded by the Department of Veterans Affairs to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for Oncotype DX cancer testing services at a VA medical facility in St. Louis. The contract was issued under the VA's Medical Laboratory Testing and Analysis Services master schedule contract and runs through March 2021. Genomic Health, a leading provider of genomic-based cancer diagnostic tests to the federal government, has received...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 (VA - VHA) awarded Genomic Health, Inc., a subsidiary of Exact Sciences Corp and Exact Sciences Laboratories, LLC doing business as Exact, a Blanket Purchase Agreement Call contract valued at nine hundred seventy thousand three hundred fifty-two United States dollars ($970,352) to provide Oncotype Genetic Testing Services. The contract has a period of performance starting on February 27, 2023...
This is a firm fixed-price contract awarded by the Department of Veterans Affairs Veterans Health Administration to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for the provision of proprietary genetic testing services for cancer diagnosis and treatment selection. The contract was issued as a Blanket Purchase Agreement (BPA) call order under Genomic Health's existing General Services Administration (GSA) Medical Laboratory Testing and Analysis Services schedule contract. The...
Genomic Health, Inc. was awarded a firm fixed price blanket purchase agreement call by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 for $114,305 to provide Oncotype Genetic Testing Services from February 2024 through February 2028. The contract has no set-aside designation. Genomic Health will deliver its Oncotype DX portfolio of assays to support cancer screening, treatment selection, and disease monitoring programs at VA medical...
This is a $98,137.17 firm fixed-price delivery order awarded by the Veterans Integrated Service Network 17 (VISN 17) of the U.S. Department of Veterans Affairs (VA) to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation. The contract is for the provision of Genomic Health's Oncotype DX cancer diagnostic testing services, which analyze gene expression to determine cancer risk, recurrence potential, and treatment benefits. This delivery order falls under the Medical Laboratory Testing...